← Back to Clinical Trials
Recruiting Phase 1 NCT06840678
Home-based Transcranial Static Magnetic Field Stimulation (tSMS) of the Supplementary Motor Area in Parkinson's Disease
Trial Parameters
Condition Parkinson's Disease
Sponsor Fundación de investigación HM
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2022-10-01
Completion 2025-08-31
Interventions
Transcranial static magnetic field stimulation (tSMS) of the supplementary motor area
Brief Summary
This is a pilot open study to test the hypothesis that home-based transcranial static magnetic field stimulation (tSMS) of the supplementary motor area is safe and feasible to modulate corticostriatal activity in patients with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * idiopathic Parkinson's disease (Brain Bank criteria) * optimal clinical response to dopaminergic medication (\>30% MDS-UPDRS-III improvement) Exclusion Criteria: * MRI-incompatible metal objects in the body (e.g. cardiac pacemakers) * presence of levodopa-induced dyskinesias * other main neuropsychiatric co-morbidity